Viewing Study NCT02428348



Ignite Creation Date: 2024-05-06 @ 3:59 AM
Last Modification Date: 2024-10-26 @ 11:42 AM
Study NCT ID: NCT02428348
Status: TERMINATED
Last Update Posted: 2017-11-28
First Post: 2015-03-31

Brief Title: EEGHOME Phase 3b of the Project Interviews
Sponsor: University Hospital Ghent
Organization: University Hospital Ghent

Study Overview

Official Title: None
Status: TERMINATED
Status Verified Date: 2017-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Project funding ended before Phase 3b could be completed
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this project is the development of an EEG-cap min 21 electrodes with user-friendly active dry electrodes that meets the expectations of the users regarding comfort and esthetics without losing sight of the functional and technical demands for recording high quality EEG signals The purpose is to use the EEG-cap to investigate clinical neurological disorders eg epilepsy The EEG-cap could also be used at home so that hospital admission in the EMU can be avoided for some patients and an increasing number of patients can be examined

Phase 3 of this Project will be divided into Phase 3a and Phase 3b

In Phase 3b of the project epilepsy patients and their family will be interviewed about different EEG-cap models in development This interview is anticipated to take approximately 1 hour

Minimum 4 - maximum 20 epilepsy patients and their family will be interviewed

The results of the interviews will be analysed by the design company pilipili nv
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None